Qube Research & Technologies LTD G1 Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $1.05 Million - $2.37 Million	476,045 Added 146.72%	800,511 $1.83 Million
Q1 2024 May 14, 2024	BUY	$2.1 - $4.83 $582,057 - $1.34 Million	277,170 Added 586.03%	324,466 $1.4 Million
Q4 2023 Feb 13, 2024	BUY	$1.12 - $3.73 $52,971 - $176,414	47,296 New	47,296 $144,000
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $477,498 - $1.52 Million	-185,797 Reduced 46.45%	214,224 $574,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $1.6 Million - $4.17 Million	309,012 Added 339.54%	400,021 $2.17 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $130,134 - $427,655	25,171 Added 38.23%	91,009 $1.14 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $198,832 - $418,828	49,216 Added 296.09%	65,838 $325,000
Q1 2022 May 09, 2022	SELL	$7.6 - $11.02 $112,670 - $163,371	-14,825 Reduced 47.14%	16,622 $126,000
Q4 2021 Feb 01, 2022	BUY	$10.16 - $16.17 $319,501 - $508,497	31,447 New	31,447 $321,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.